Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry.
Hagemeyer D, Merdad A, Sierra LV, Ruberti A, Kargoli F, Bouchat M, Boiago M, Moschovitis A, Deva DP, Stolz L, Ong G, Peterson MD, Piazza N, Taramasso M, Dumonteil N, Modine T, Latib A, Praz F, Hausleiter J, Fam NP. Hagemeyer D, et al. Among authors: moschovitis a. JACC Cardiovasc Interv. 2024 Feb 26;17(4):552-560. doi: 10.1016/j.jcin.2023.12.016. JACC Cardiovasc Interv. 2024. PMID: 38418058
Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial.
Pilgrim T, Räber L, Limacher A, Löffel L, Wenaweser P, Cook S, Stauffer JC, Togni M, Vogel R, Garachemani A, Moschovitis A, Khattab AA, Seiler C, Meier B, Jüni P, Windecker S. Pilgrim T, et al. Among authors: moschovitis a. JACC Cardiovasc Interv. 2011 Jun;4(6):672-82. doi: 10.1016/j.jcin.2011.02.017. JACC Cardiovasc Interv. 2011. PMID: 21700254 Free article. Clinical Trial.
The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents.
Pilgrim T, Vetterli F, Kalesan B, Stefanini GG, Räber L, Stortecky S, Gloekler S, Binder RK, Wenaweser P, Moschovitis A, Khattab AA, Buellesfeld L, Zwahlen M, Meier B, Jüni P, Windecker S. Pilgrim T, et al. Among authors: moschovitis a. Circ Cardiovasc Interv. 2012 Apr;5(2):202-10. doi: 10.1161/CIRCINTERVENTIONS.111.965749. Epub 2012 Mar 27. Circ Cardiovasc Interv. 2012. PMID: 22456025
Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L, Baumgartner S, Garcia-Garcia HM, Kalesan B, Justiz J, Pilgrim T, Moschovitis A, Khattab AA, Buellesfeld L, Wenaweser P, Meier B, Serruys PW, Jüni P, Windecker S. Räber L, et al. Among authors: moschovitis a. JACC Cardiovasc Interv. 2012 Sep;5(9):946-57. doi: 10.1016/j.jcin.2012.05.012. JACC Cardiovasc Interv. 2012. PMID: 22995882 Free article. Clinical Trial.
Clinical outcomes of patients with low-flow, low-gradient, severe aortic stenosis and either preserved or reduced ejection fraction undergoing transcatheter aortic valve implantation.
O'Sullivan CJ, Stortecky S, Heg D, Pilgrim T, Hosek N, Buellesfeld L, Khattab AA, Nietlispach F, Moschovitis A, Zanchin T, Meier B, Windecker S, Wenaweser P. O'Sullivan CJ, et al. Among authors: moschovitis a. Eur Heart J. 2013 Nov;34(44):3437-50. doi: 10.1093/eurheartj/eht408. Epub 2013 Oct 3. Eur Heart J. 2013. PMID: 24096324 Free article.
Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
Gloekler S, Shakir S, Doblies J, Khattab AA, Praz F, Guerios Ê, Koermendy D, Stortecky S, Pilgrim T, Buellesfeld L, Wenaweser P, Windecker S, Moschovitis A, Jaguszewski M, Landmesser U, Nietlispach F, Meier B. Gloekler S, et al. Among authors: moschovitis a. Clin Res Cardiol. 2015 Aug;104(8):656-65. doi: 10.1007/s00392-015-0828-1. Epub 2015 Mar 4. Clin Res Cardiol. 2015. PMID: 25736061
Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
Zanchin T, Räber L, Koskinas KC, Piccolo R, Jüni P, Pilgrim T, Stortecky S, Khattab AA, Wenaweser P, Bloechlinger S, Moschovitis A, Frenk A, Moro C, Meier B, Fiedler GM, Heg D, Windecker S. Zanchin T, et al. Among authors: moschovitis a. Circ Cardiovasc Interv. 2016 Jun;9(6):e003202. doi: 10.1161/CIRCINTERVENTIONS.115.003202. Circ Cardiovasc Interv. 2016. PMID: 27296200
Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
Koskinas KC, Shakir S, Fankhauser M, Nietlispach F, Attinger-Toller A, Moschovitis A, Wenaweser P, Pilgrim T, Stortecky S, Praz F, Räber L, Windecker S, Meier B, Gloekler S. Koskinas KC, et al. Among authors: moschovitis a. JACC Cardiovasc Interv. 2016 Jul 11;9(13):1374-83. doi: 10.1016/j.jcin.2016.04.019. JACC Cardiovasc Interv. 2016. PMID: 27388826 Free article.
Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC, Räber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blöchlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Jüni P, Heg D, Windecker S. Koskinas KC, et al. Among authors: moschovitis a. JACC Cardiovasc Interv. 2016 Jul 25;9(14):1473-83. doi: 10.1016/j.jcin.2016.04.027. JACC Cardiovasc Interv. 2016. PMID: 27478115 Free article.
84 results